Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-08-06 21:47:31 ET
Seres Therapeutics, Inc. (MCRB)
Q2 2025 Earnings Conference Call
August 06, 2025, 08:30 AM ET
Company Participants
Carlo Tanzi - Corporate Participant
Investor Relations - Corporate Participant
Dennis M. Walling - Senior VP of Clinical Development & Head of Clinical Research...
Read the full article on Seeking Alpha
For further details see:
Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript
Seres Therapeutics Inc.
NASDAQ: MCRB
MCRB Trading
-0.46% G/L:
$8.69 Last:
19,989 Volume:
$9 Open:
MCRB Latest News
March 12, 2026 07:00:00 am
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
MCRB Stock Data
$129,727,082
7,418,146
0.38%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
